```json
{
"content": [
{
"type": "paragraph",
"content": "The Drug Repurposing market involves identifying and developing new therapeutic applications for existing pharmaceuticals, reducing time-to-market and R&D costs compared to de novo drug discovery. This industry is gaining strategic relevance as global healthcare systems prioritize cost-effective, accelerated solutions for unmet medical needs. The Drug Repurposing market size is projected to expand significantly, driven by advancements in AI-driven drug discovery, increasing incidence of chronic diseases, and regulatory incentives for innovative therapies. According to recent data, the global market reached $16.8 billion in 2025, with a robust CAGR of 9.2% anticipated from 2026 to 2033, reflecting strong growth outlook and industry expansion across therapeutic applications."
},
{
"type": "chart",
"chartType": "segment-stacked",
"data": {
"segments": ["Oncology", "Infectious Diseases", "Neurological Disorders"],
"periods": ["2021", "2022", "2023", "2024", "2025", "2026", "2027", "2028", "2029", "2030", "2031", "2032", "2033"],
"values": [
[12, 13, 14, 15, 16, 18, 20, 22, 24, 26, 28, 30, 32], // Oncology
[9, 10, 11, 12, 13, 14, 16, 18, 20, 22, 24, 26, 28], // Infectious Diseases
[6, 7, 8, 9, 10, 11, 13, 15, 17, 19, 21, 23, 25] // Neurological Disorders
]
}
},
{
"type": "paragraph",
"content": "Key macro drivers include technological shifts such as machine learning algorithms streamlining drug-screening processes, regulatory tailwinds like FDA Fast Track designations for repurposed drugs, and supply-chain dynamics favoring cost-efficient production. North America remains the largest regional market due to high R&D investments and biotechnology infrastructure, while Asia-Pacific is the fastest-growing region, fueled by collaborative public-private initiatives and rising healthcare access. Strategic partnerships between pharmaceutical firms and academic institutions are intensifying competitive intensity, ensuring the Drug Repurposing market forecast remains a cornerstone of market forecast strategies through 2033."
}
]
}
```
